T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Champion Homes
SKY
$5.23B
| $25.1M | ﹤0.01% |
487,716
+6,520
| +1% | +$347K |
|
852
Omnicell
OMCL
$1.72B
| $25M | ﹤0.01% |
495,535
+2,928
| +0.6% | +$176K |
|
853
AES
AES
$10.5B
| $24.9M | ﹤0.01% |
866,350
+2,294
| +0.3% | +$61.8K |
|
854
BellRing Brands
BRBR
$1.28B
| $24.8M | ﹤0.01% |
965,674
-47,409
| -5% | -$1.14M |
|
855
Iovance Biotherapeutics
IOVA
$2.95B
| $24.6M | ﹤0.01% |
3,848,731
-862,583
| -18% | -$6.73M |
|
|
CSW
856
CSW Industrials
CSW
$5.59B
| $24.5M | ﹤0.01% |
211,559
+9,418
| +5% | +$1.13M |
|
857
Clorox
CLX
$12.9B
| $24.4M | ﹤0.01% |
173,585
-484
| -0.3% | -$68.7K |
|
|
AQUA
858
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $24.3M | ﹤0.01% |
613,187
+2,841
| +0.5% | +$112K |
|
859
BHP
BHP
$222B
| $24.2M | ﹤0.01% |
390,593
-40,999
| -9% | -$2.31M |
|
860
Freshworks
FRSH
$3.51B
| $24.2M | ﹤0.01% |
1,644,665
+7,786
| +0.5% | +$108K |
|
861
CONMED
CNMD
$1.49B
| $24.2M | ﹤0.01% |
272,770
+307
| +0.1% | +$25.5K |
|
862
Evolent Health
EVH
$527M
| $23.8M | ﹤0.01% |
847,129
+94,043
| +12% | +$2.7M |
|
863
Tradeweb Markets
TW
$22.3B
| $23.8M | ﹤0.01% |
366,040
-25,462
| -7% | -$1.5M |
|
864
Bio-Rad Laboratories Class A
BIO
$9.66B
| $23.5M | ﹤0.01% |
55,828
-11,450
| -17% | -$4.62M |
|
865
Mid-America Apartment Communities
MAA
$15.6B
| $23.4M | ﹤0.01% |
148,925
-1,766
| -1% | -$275K |
|
|
K
866
DELISTED
Kellanova
K
| $23.4M | ﹤0.01% |
349,406
-2,406
| -0.7% | -$163K |
|
867
Pliant Therapeutics
PLRX
$66.9M
| $23.3M | ﹤0.01% |
1,205,734
-26,110
| -2% | -$546K |
|
868
Federal Signal
FSS
$7.51B
| $23.2M | ﹤0.01% |
499,810
+60,068
| +14% | +$2.76M |
|
869
Graco
GGG
$13.3B
| $23.2M | ﹤0.01% |
344,995
+2,675
| +0.8% | +$178K |
|
|
NVEE
870
DELISTED
NV5 Global
NVEE
| $23.1M | ﹤0.01% |
698,520
+147,988
| +27% | +$5.14M |
|
871
Iron Mountain
IRM
$37.7B
| $23M | ﹤0.01% |
462,263
+16,689
| +4% | +$842K |
|
|
AMED
872
DELISTED
Amedisys
AMED
| $22.8M | ﹤0.01% |
272,929
-73,274
| -21% | -$6.61M |
|
|
MRO
873
DELISTED
Marathon Oil Corporation
MRO
| $22.7M | ﹤0.01% |
839,284
-73,685
| -8% | -$2.14M |
|
874
Invitation Homes
INVH
$18B
| $22.6M | ﹤0.01% |
763,250
+8,349
| +1% | +$265K |
|
|
LSI
875
DELISTED
Life Storage, Inc.
LSI
| $22.6M | ﹤0.01% |
229,554
-469,653
| -67% | -$49.2M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.